Segment Information - Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Mar. 31, 2024 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents [Line Items] | ||||||||
| Revenues | $ 1,853,000 | $ 1,331,000 | $ 3,268,000 | $ 2,591,000 | $ 5,707,000 | $ 4,155,000 | ||
| Cost of revenues | 304,000 | 213,000 | 496,000 | 409,000 | 866,000 | 782,000 | ||
| R&D expenses- excluding stock-based compensation expenses | 2,060,000 | 1,840,000 | 7,568,000 | 3,691,000 | 6,894,000 | 4,653,000 | ||
| S&M expenses- excluding stock-based compensation expenses | 1,304,000 | 1,456,000 | 2,559,000 | 3,192,000 | 5,696,000 | 3,316,000 | ||
| G&A expenses- excluding stock-based compensation expenses | 1,305,000 | 1,241,000 | 7,589,000 | 2,756,000 | 4,221,000 | 4,602,000 | ||
| Operating loss | (3,120,000) | (3,419,000) | (14,944,000) | (7,457,000) | 11,970,000 | 9,198,000 | ||
| Net loss | (3,439,000) | (2,446,000) | $ (15,610,000) | (14,209,000) | (5,760,000) | (12,819,000) | (15,610,000) | |
| Cash and cash equivalents | 794,000 | 183,000 | 794,000 | 183,000 | $ 927,000 | 294,000 | 927,000 | |
| TRAILBLAZER HOLDINGS, INC. [Member] | ||||||||
| Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents [Line Items] | ||||||||
| Operating loss | (53,820) | (156,348) | ||||||
| Net loss | (53,820) | (156,348) | ||||||
| Chief Operating Decision Maker [Member] | ||||||||
| Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents [Line Items] | ||||||||
| Revenues | 1,853,000 | 1,331,000 | 3,268,000 | 2,591,000 | 5,707,000 | 4,155,000 | ||
| Cost of revenues | 304,000 | 213,000 | 496,000 | 409,000 | 866,000 | 782,000 | ||
| R&D expenses- excluding stock-based compensation expenses | 1,922,000 | 1,510,000 | 4,737,000 | 2,825,000 | 5,800,000 | 4,076,000 | ||
| S&M expenses- excluding stock-based compensation expenses | 1,308,000 | 1,277,000 | 2,470,000 | 2,787,000 | 5,141,000 | 3,265,000 | ||
| G&A expenses- excluding stock-based compensation expenses | 1,216,000 | 884,000 | 5,069,000 | 1,772,000 | 2,846,000 | 3,679,000 | ||
| Stock based compensation expenses | 223,000 | 866,000 | 5,440,000 | 2,255,000 | 3,024,000 | 1,551,000 | ||
| Operating loss | 3,120,000 | 3,419,000 | 14,944,000 | 7,457,000 | 11,970,000 | 9,198,000 | ||
| Finance expenses (income) | 255,000 | 992,000 | 799,000 | 1,716,000 | 335,000 | 6,182,000 | ||
| Interest expense | 493,000 | 216,000 | ||||||
| Taxes on Income | 64,000 | 19,000 | 64,000 | 19,000 | 21,000 | 14,000 | ||
| Net loss | 3,439,000 | 2,446,000 | 14,209,000 | 5,760,000 | 12,819,000 | 15,610,000 | ||
| Cash and cash equivalents | $ 794,000 | $ 183,000 | $ 794,000 | $ 183,000 | 927,000 | 294,000 | $ 927,000 | |
| Chief Operating Decision Maker [Member] | TRAILBLAZER HOLDINGS, INC. [Member] | ||||||||
| Schedule of CODM is also Regularly Provided with Information on Significant Expenses and Cash and Cash Equivalents [Line Items] | ||||||||
| Operating expenses | $ 53,820 | $ 156,348 | ||||||
| X | ||||||||||
- Definition Amount of taxes on income. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|